Financials

  • Market Capitalization 982.46 M
  • Employee 108
  • Founded 2017
  • CEO N/A
  • Website www.januxrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZHSKH11
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.54
Relación precio/flujo de caja
85.51

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2457
SANA
Sana Biotechnology, Inc. - Common Stock
3.64 USD0.00%-4.46%+32.36%-13.74%1.01 B USD
2476
AVTX
Avalo Therapeutics, Inc. - Common Stock
18.78 USD-0.69%-5.82%+25.12%+282.48%987.18 M USD
2484
ANRO
Alto Neuroscience, Inc. Common Stock
26.89 USD-4.07%+5.87%+24.95%+888.60%943.68 M USD
2486
VOR
Vor Biopharma Inc. - Common Stock
18.25 USD+1.22%-8.20%+23.73%+39.31%988.89 M USD

Noticias